Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Distigmine"'
Autor:
Michał Janusz Łyszkowicz, Małgorzata Barbara Stańczyk, Marek Krakós, Łukasz Przysło, Marcin Tkaczyk
Publikováno v:
Pediatria Polska, Vol 99, Iss 2, Pp 153-157 (2024)
Acute urinary retention is rare in children and has various causes, but in 10% of cases has unclear aetiology. It is more common in boys and is often associated with urinary tract inflammation or mechanical obstruction. A 14-year-old girl presented w
Externí odkaz:
https://doaj.org/article/bf4bb3a63641433db80059f923ba32de
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
岡山赤十字病院医学雑誌 = The Okayama Red Cross Hospital Journal of Medicine. 31:35-38
症例は98歳，女性．既往歴に左腎盂尿管移行部狭窄症があり，全身麻酔下での尿管ステントの定期交換中であった．排尿障害に対しては4 年前からジスチグミン臭化物の内服中であり，副
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::19e11b1843343be7ed767f3a71f4d50c
http://id.nii.ac.jp/1063/00016993/
http://id.nii.ac.jp/1063/00016993/
Autor:
Yousry M. Issa, Amal F. Khorshid
Publikováno v:
Journal of Advanced Research, Vol 2, Iss 1, Pp 25-34 (2011)
The construction and electrochemical response characteristics of poly(vinylchloride) (PVC) membrane selective electrodes for the determination of distigmine (Ds) are described. The sensing membrane comprised an ion-pair based on distigmine phosphomol
Externí odkaz:
https://doaj.org/article/8965fe2e21dd4837bcf53458492bc57d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Masakatsu Motomura, Naonobu Futamura, Hiroshi Yamasaki, Nobuo Kohara, Itaru Funakawa, Shunsuke Yoshimura
Publikováno v:
Internal medicine (Tokyo, Japan). 61(7)
We herein report two P/Q-type voltage-gated calcium channel (VGCC) antibody-positive Lambert-Eaton myasthenic syndrome (LEMS) patients who responded dramatically to cholinesterase inhibitors. Patient 1, a 76-year-old man, had small-cell lung cancer a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44346d4c963205226d8e5039f6dbe2e3
https://pubmed.ncbi.nlm.nih.gov/34544947
https://pubmed.ncbi.nlm.nih.gov/34544947
Autor:
Keisuke Obara, Yoshio Tanaka
Publikováno v:
Pharmacology. 105:135-144
Distigmine bromide (distigmine) is a reversible carbamate cholinesterase (ChE) inhibitor that is used to treat myasthenia gravis. In Japan, it is also used as a remedy for urination disorder (underactive bladder). The most distinctive pharmacological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79829a20eb70d5fc27b087c622af9159
https://doi.org/10.1159/000503453
https://doi.org/10.1159/000503453
Autor:
Keisuke Obara, Yoshio Tanaka
Publikováno v:
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 141(2)
Distigmine bromide (distigmine) is a carbamate cholinesterase (ChE) inhibitor, which is mainly used for the treatment of myasthenia gravis. Distigmine is also used in Japan for the treatment for underactive bladder and glaucoma. The effectiveness of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dae3d7a50e7cf388583233a1ff729d12
https://pubmed.ncbi.nlm.nih.gov/33518645
https://pubmed.ncbi.nlm.nih.gov/33518645
Publikováno v:
Biologicalpharmaceutical bulletin. 43(8)
Although distigmine is known to sometimes cause severe adverse drug reactions (ADRs), such as cholinergic crisis, there are limited data on the risk factors for these ADRs. In this study, we defined a serum cholinesterase (sChE) cutoff level for earl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e5a9f70b070ecc2cf5d9fd7320bd172
https://pubmed.ncbi.nlm.nih.gov/32741950
https://pubmed.ncbi.nlm.nih.gov/32741950
Autor:
Jun Kida, Hiroko Mashimo, Daisuke Wakamatsu, Hidekazu Matsuya, Noritoshi Sekido, Takeya Otsuki, Hiroki Okada
Publikováno v:
Lower urinary tract symptomsREFERENCES. 12(3)
OBJECTIVES Diabetic cystopathy (DC) is recognized as one of the major etiologies of underactive bladder (UAB)/detrusor underactivity (DU). Although DC was first reported about three decades ago, there is a distinct lack of effective pharmacological m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f34bd2aba0e9ce54bfc5024e3a0b317
https://pubmed.ncbi.nlm.nih.gov/32410343
https://pubmed.ncbi.nlm.nih.gov/32410343